Evidence map›Paper›PMID 30057914›Full record

ArticleJournal of immunology research2018

CTLA4Ig Improves Murine iTreg Induction via TGF

Nina Pilat, Benedikt Mahr, Martina Gattringer, Ulrike Baranyi, Thomas Wekerle

Abstract read
In one paragraph

Article in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nina PilatSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-4071-9397
Benedikt MahrSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Martina GattringerSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Ulrike BaranyiSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Thomas WekerleSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5159-2796

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blockade of the CD28:CD80/86 costimulatory pathway has been shown to be potent in blocking T cell activation

Indexed as

Organ TransplantationAbataceptAnimalsB7-1 AntigenB7-2 AntigenCD28 AntigensCell DifferentiationCells, CulturedFemaleGraft RejectionImmunosuppression TherapyImmunosuppressive AgentsLymphocyte ActivationMiceMice, Inbred C57BLT-Lymphocytes, RegulatoryAbataceptB7-1 AntigenB7-2 AntigenCD28 AntigensImmunosuppressive AgentsTransforming Growth Factor beta

Identifiers

PMID30057914
PMCPMC6051081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.